ACT Group for Family Caregivers of Stroke Survivors
The Wright Institute · NCT07528261
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- September 1, 2025
- Record last updated
- May 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to evaluate the efficacy of group-based ACT intervention in improving the levels of psychological distress in caregivers of stroke survivors. The main questions it aims to answer are:
- Does group-based ACT intervention improve the levels of psychological distress and QoL in family caregivers of stroke survivors?
- Do the levels of psychological flexibility and experiential avoidance in family caregivers of stroke survivors mediate the outcome of the ACT Group?
The researcher will compare the experimental group (i.e., participants who received group-based ACT intervention) with the control group (i.e., participants who did not receive group-based ACT intervention) to assess whether the group-based ACT intervention is effective in mitigating caregiver stress and improving caregivers' QoL.
Participants in the experimental group will:
- Receive a 5-weekly, 1.5-hour group intervention based on the ACT Model;
- Complete study measures at pre-treatment, immediate post-treatment, and 2-month follow-up.
Participants in the control group will not receive the group intervention but will complete the same study measures.
Being studied: Group-based ACT Intervention
Conditions: Caregiver Stress; Caregiver Stress Syndrome; Caregiver Burnout; Caregiver Distress; Caregiver Exhaustion; Caregiver Health Related QOL; Caregiver Burden for Those Who Care for Adults With Impaired Functional Status; Caregiver Quality of Life; Caregiver Burden; Caregiver Mental Health; Caregiver Resilience and Stress; Caregiver Sense of Control Over Life; Caregiver Awareness; Caregiver Stress in Chronic Mental Illness
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 40 or above.
- Taking the primary responsibility for the care of a family member suffering from stroke (i.e. spending at least 70% of the time on performing caregiving tasks).
- The stroke patient has been discharged from hospital and is currently living with the caregiver.
- Having cared for the stroke patient for at least six months, including at least two months after discharge.
- CSAQ score (as determied during pre-group screening meeting) indicates a high level of distress, as evidenced by one of the following: a) participant answered "Yes" to either or both questions 4 and 11; b) total "Yes" scores = 10 or more; c) score on question 17 is 6 or higher; d) score on question 18 is 6 or higher.
- Able to use a computer and has internet access.
- Able to provide informed consent to participate.
Exclusion Criteria
- is below 40 years old.
- has any comorbid mental disorder or disability that may impede group participation (e.g., personality disorder, learning disability).
- does not understand English (read, write, listen, and speak).
- has current active suicidal/homicidal ideation.
- is currently receiving psychological intervention (individual or group).
Recruiting US locations
The Wright Institute
Alameda, CA 94501-7888
Site contact: CHI WAI YIU, PsyD Candidate · 5109743626 · jyiu@wi.edu
Study contacts (from the official record)
- Chi Wai Yiu, PsyD Candidate · 510-974-3626 · jyiu@wi.edu
Similar studies in California
All mental health studies in California →- RecruitingHealthy volunteersEarly Phase 1
Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Neurosterix
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Los Alamitos, CA + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- Anaheim, CA + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Inflammatory Challenge and Fear
University of California, San Francisco
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18–65